Rating Change
HC Wainwright & Co. reiterated its Buy rating on Nektar Therapeutics (NASDAQ:NKTR) on October 02, 2026.
reiterateNASDAQ:NKTR
HC Wainwright & Co. Reiterates Buy Rating on Nektar Therapeutics (NKTR)
HC Wainwright & Co. reiterated its Buy rating on Nektar Therapeutics (NASDAQ:NKTR) on October 02, 2026.
At publication ·
What changed
Nektar Therapeutics (NASDAQ:NKTR) · reiterate
- Firm
- HC Wainwright & Co.
- Rating
- Buy to Buy
- Price at event
- $42.17
- Market capitalization
- $1.0B
At a glance
Key takeaways
- HC Wainwright & Co. reiterated a Buy rating on Nektar Therapeutics (NKTR) on October 2, 2026, while the stock trades at $42.17 with a $1.0B market capitalization.
Market Context
Nektar Therapeutics operates in the Healthcare sector. The stock currently trades at $42.17 with a market capitalization of $1.0B.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Nektar Therapeutics.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Nektar Therapeutics
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 02, 2026 | HC Wainwright & Co. | Buy | N/A |
| Sep 28, 2026 | BTIG | Buy | N/A |
| Sep 25, 2026 | BTIG | Buy | N/A |
| Sep 23, 2026 | Wedbush | Neutral | N/A |
| Sep 16, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View NKTR Stock Page
Frequently Asked Questions
What does the Buy rating mean for NKTR?
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on Nektar Therapeutics (NASDAQ:NKTR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the NKTR forecast page.